Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial
Titel:
Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial
Auteur:
Delforge, Michel Patel, Krina Eliason, Laurie Dhanda, Devender Shi, Ling Guo, Shien Marshall, Thomas S Arnulf, Bertrand Cavo, Michele Nooka, Ajay Manier, Salomon Callander, Natalie Giralt, Sergio Einsele, Hermann Ailawadhi, Sikander Popa McKiver, Mihaela Cook, Mark RodrÃguez-Otero, Paula